SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?


To: Matthew Cooper who wrote (1819)3/18/1998 3:42:00 PM
From: Joe Wesley  Read Replies (1) | Respond to of 4676
 
Hi Matt:

Isis 2302 (the Crohn's drug) is part of a 50/50 partnership in the area of cell adhesion with Boehringer Ingelheim (BI).

Amateur